Jonathan Silverstein's Net Worth

$622 Million

Estimate Recalculated Feb 29, 2024 05:54PM EST

Who is Jonathan Silverstein?

Jonathan Silverstein has an estimated net worth of $622 Million. This is based on reported shares across multiple companies, which include AVEDRO INC, RHYTHM PHARMACEUTICALS, INC., INSULET CORP, Relypsa Inc, GLAUKOS Corp, INTERCEPT PHARMACEUTICALS INC, Arcutis Biotherapeutics, Inc., resTORbio, Inc., scPharmaceuticals Inc., AVANIR PHARMACEUTICALS, Roka BioScience, Inc., Audentes Therapeutics, Inc., NxStage Medical, Inc., and LIFECELL CORP.

SEC CIK

Jonathan Silverstein's CIK is 0001171005

Past Insider Trading and Trends

2013 was Jonathan Silverstein's most active year for acquiring shares with 15 total transactions. Jonathan Silverstein's most active month to acquire stocks was the month of June. 2015 was Jonathan Silverstein's most active year for disposing of shares, totalling 49 transactions. Jonathan Silverstein's most active month to dispose stocks was the month of February. 2012 saw Jonathan Silverstein paying a total of $26,000,010.00 for 12,664,479 shares, this is the most they've acquired in one year. In 2014 Jonathan Silverstein cashed out on 31,227,436 shares for a total of $77,167,894.25, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

AVEDRO INC No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-100.00%
-4.24M
0
Nov 21
Form 4
0
0
Jun 14
Form 4
+2,681.91%
4.09M
4.24M
Feb 19
Form 3
0
0
No matching records found

RHYTHM PHARMACEUTICALS, INC. (RYTM) Snapshot price: $47.935

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
0
0
Form 3
0
0
No matching records found

INSULET CORP (PODD) Snapshot price: $200.06

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
1.57M
1.57M
May 15 - May 18
Form 3/A
0
0
Form 3
0
0
No matching records found

Relypsa Inc No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
9.94M
$7.16
-$300,102.00
9.94M
Nov 20
Form 3
0
0
No matching records found

GLAUKOS Corp (GKOS) Snapshot price: $94.8625

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-36.45%
-836.50K
$31.81
-$26,787,191.74
1.46M
Mar 2 - Mar 6
Form 4
0
0
Dec 13
Form 4
-9.62%
-580.20K
$38.78
-$22,472,822.20
5.45M
Aug 31 - Sep 5
Form 4
-6.38%
-325.00K
$38.05
-$12,326,042.80
4.77M
Aug 15 - Aug 17
Form 4
-4.91%
-382.54K
$45.49
-$17,339,215.44
7.4M
Mar 10 - Mar 14
Form 4
-2.56%
-55.77K
$47.05
-$2,624,072.60
2.12M
Mar 3
Form 4
-4.17%
-292.94K
$33.71
-$9,869,285.26
6.73M
Aug 10 - Aug 12
Form 4
-14.67%
-425.00K
$30.59
-$13,000,750.00
2.47M
Aug 3
Form 4
0
0
Jun 2
Form 4
0
0
Jul 23
Form 4
+100.55%
2.9M
$18.00
-$211,212.00
5.78M
Jun 30
Form 3
0
0
No matching records found